Literature DB >> 16174943

Respiratory dysfunction in Guillain-Barré Syndrome.

David Orlikowski1, Hélène Prigent, Tarek Sharshar, Frédéric Lofaso, Jean Claude Raphael.   

Abstract

Guillain-Barré Syndrome is the leading cause of nontraumatic acute paralysis in industrialized countries. About 30% of patients have respiratory failure requiring intensive care unit (ICU) admission and invasive mechanical ventilation. Progressive weakness of both the inspiratory and the expiratory muscles is the mechanism leading to respiratory failure. Aspiration pneumonia and atelectasis are common consequences of the bulbar muscle weakness and ineffective cough. The classical signs of respiratory distress occur too late to serve as guidelines for management, and measurements of vital capacity and static respiratory pressures are useful to determine the best times for starting and stopping mechanical ventilation. Several factors present at admission and during the ICU stay are known to predict a need for invasive mechanical ventilation. They include rapidly progressive motor weakness, involvement of both the peripheral limb and the axial muscles, ineffective cough, bulbar muscle weakness, and a rapid decrease in vital capacity. Specific treatments (plasma exchange and intravenous immunoglobulins) have decreased both the number of patients requiring ventilation and the duration of ventilation. The need for mechanical ventilation is associated with residual functional impairments, although all patients eventually recover normal respiratory muscle function.

Entities:  

Mesh:

Year:  2004        PMID: 16174943     DOI: 10.1385/NCC:1:4:415

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  65 in total

1.  Campylobacter diarrhea and Guillain-Barré syndrome.

Authors:  A H Ropper
Journal:  Arch Neurol       Date:  1988-06

Review 2.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

3.  A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

Authors:  J B Winer; R A Hughes; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

4.  Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group.

Authors:  L H Visser; P I Schmitz; J Meulstee; P A van Doorn; F G van der Meché
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

Review 5.  Corticosteroids for treating Guillain-Barré syndrome.

Authors:  R A Hughes; F G van der Meché
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  Post-intubation pulmonary function test in Guillain-Barré syndrome.

Authors:  N D Lawn; E F Wijdicks
Journal:  Muscle Nerve       Date:  2000-04       Impact factor: 3.217

Review 7.  Pearls and pitfalls in the intensive care management of Guillain-Barré syndrome.

Authors:  J A Chalela
Journal:  Semin Neurol       Date:  2001-12       Impact factor: 3.420

8.  Early predictors of mechanical ventilation in Guillain-Barré syndrome.

Authors:  Tarek Sharshar; Sylvie Chevret; Frederic Bourdain; Jean-Claude Raphaël
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

Review 9.  Intensive management and treatment of severe Guillain-Barré syndrome.

Authors:  E F Hund; C O Borel; D R Cornblath; D F Hanley; G M McKhann
Journal:  Crit Care Med       Date:  1993-03       Impact factor: 7.598

10.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  16 in total

Review 1.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

2.  Respiratory Muscle Assessment in Acute Guillain-Barré Syndrome.

Authors:  S Walterspacher; A Kirchberger; J Lambeck; D J Walker; A Schwörer; W D Niesen; W Windisch; F Hamzei; H J Kabitz
Journal:  Lung       Date:  2016-08-09       Impact factor: 2.584

3.  Vital capacity versus maximal inspiratory pressure in patients with Guillain-Barré syndrome and myasthenia gravis.

Authors:  Hélène Prigent; David Orlikowski; Nadège Letilly; Line Falaize; Djilali Annane; Tarek Sharshar; Frédéric Lofaso
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 4.  Neuromuscular disorders and sleep in critically ill patients.

Authors:  Muna Irfan; Bernardo Selim; Alejandro A Rabinstein; Erik K St Louis
Journal:  Crit Care Clin       Date:  2015-07       Impact factor: 3.598

5.  An unusual occurrence of opsoclonus and liver enzymes elevation in a patient with acute motor and sensory axonal neuropathy subtype of Guillain-Barré syndrome.

Authors:  Hasan Alzuhaily; Eman Khashaneh; Sanaa Albkhetan; Fatima Abbas
Journal:  BMC Neurol       Date:  2022-03-18       Impact factor: 2.474

6.  Guillain-Barré syndrome in two patients with respiratory failure and a review of the Japanese literature.

Authors:  Erei Sohara; Takeshi Saraya; Kojiro Honda; Atsuko Yamada; Toshiya Inui; Yukari Ogawa; Mitsuru Sada; Naoki Tsujimoto; Masuo Nakamura; Akiko Tsuchiya; Masaki Saito; Chizuko Oishi; Atsuro Chiba; Hajime Takizawa; Hajime Goto
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

7.  Translational strategies in peripheral neuroinflammation and neurovascular repair.

Authors:  Eroboghene E Ubogu
Journal:  Transl Neurosci       Date:  2012-12-01       Impact factor: 1.757

Review 8.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

9.  Guillain-Barre syndrome: Demographics, clinical profile & seasonal variation in a tertiary care centre of central India.

Authors:  Manisha Shrivastava; Shah Nehal; Navaid Seema
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

10.  Coexisting infectious diseases on admission as a risk factor for mechanical ventilation in patients with Guillain-Barré syndrome.

Authors:  Shinichiro Kobori; Tatsuhiko Kubo; Makoto Otani; Keiji Muramatsu; Yoshihisa Fujino; Hiroaki Adachi; Hiromasa Horiguchi; Kiyohide Fushimi; Shinya Matsuda
Journal:  J Epidemiol       Date:  2017-03-07       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.